Advanced Biomed (NASDAQ:ADVB) Releases Quarterly Earnings Results

Advanced Biomed (NASDAQ:ADVB) announced its quarterly earnings data on Friday. The company reported ($0.38) EPS for the quarter, Zacks reports.

Advanced Biomed Stock Down 0.7%

Shares of Advanced Biomed stock traded down $0.03 during trading on Friday, reaching $4.40. The company’s stock had a trading volume of 13,563 shares, compared to its average volume of 391,198. The business’s 50 day simple moving average is $5.19. Advanced Biomed has a 12-month low of $3.61 and a 12-month high of $25.60. The firm has a market capitalization of $5.98 million, a P/E ratio of 1.16 and a beta of 0.56.

Analyst Ratings Changes

Separately, Weiss Ratings began coverage on shares of Advanced Biomed in a research note on Monday, January 26th. They set a “sell (e+)” rating on the stock. One analyst has rated the stock with a Sell rating, According to MarketBeat, the company presently has a consensus rating of “Sell”.

Advanced Biomed Company Profile

Our Mission We are committed to the application research of integrating semiconductor technology and biotechnology. Through the enrichment, capture, and identification of circulating tumor cells and related tumor marker cells in the field of liquid biopsy, we aim to provide cancer patients with rapid and affordable assay products and services. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. We are a holding company incorporated in the State of Nevada.